Newsletter

Daily Review: A Second Malaria Vaccine

Daily Review: A Second Malaria Vaccine
A mother holds her baby receiving a malaria vaccine as part of a trial at the Walter Reed Project Research Center in Kombewa, western Kenya, Oct. 30, 2009 (AP photo by Karel Prinsloo).

Today at WPR, we’re covering a significant vulnerability in the Russia-China strategic partnership and China’s global development ambitions.

But first, here’s our take on today’s top story:

Malaria vaccine: The World Health Organization has approved a new anti-malaria vaccine. The R21/Matrix-M, developed by Oxford University, is the second such vaccine to be recommended by the WHO and offers a cheaper and more accessible option to combat the disease. (Washington Post)

Keep reading for free

Already a subscriber? Log in here .

Get instant access to the rest of this article by creating a free account below. You'll also get access to three articles of your choice each month and our free newsletter:
Subscribe for an All-Access subscription to World Politics Review
  • Immediate and instant access to the full searchable library of tens of thousands of articles.
  • Daily articles with original analysis, written by leading topic experts, delivered to you every weekday.
  • The Daily Review email, with our take on the day’s most important news, the latest WPR analysis, what’s on our radar, and more.
Subscribe Today